The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Attention Deficit Hyperactivity Disorder (ADHD) Market Insights and Forecast to 2028
Synopsis
Effective treatment of ADHD. ADHD refers to a group of syndromes that occur in childhood and are characterized by obvious difficulty in concentration, short duration of attention, hyperactivity or impulsivity compared with children of the same age.
Market Analysis and Insights: Global Attention Deficit Hyperactivity Disorder (ADHD) Market
The global Attention Deficit Hyperactivity Disorder (ADHD) market size is projected to reach US$ 19380 million by 2028, from US$ 12240 million in 2021, at a CAGR of 6.7% during 2022-2028.
There are two main types of drugs used to treat ADHD: stimulants and non-stimulants
The main manufacturers of stimulants are in Europe and America, and the main manufacturers of non-stimulants are in China.
ADHD is mainly used in hospital pharmacies and retail pharmacies. Among them, in 2020, the market share of retail pharmacies accounted for approximately 83%
Takeda has the highest market share in ADHD by major global companies, which is much higher than the market share of other companies, about 21% in 2020.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Attention Deficit Hyperactivity Disorder (ADHD) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Attention Deficit Hyperactivity Disorder (ADHD) market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Attention Deficit Hyperactivity Disorder (ADHD) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Attention Deficit Hyperactivity Disorder (ADHD) market.
Global Attention Deficit Hyperactivity Disorder (ADHD) Scope and Market Size
Attention Deficit Hyperactivity Disorder (ADHD) market is segmented by players, region (country), by Type and by Distribution Channel. Players, stakeholders, and other participants in the global Attention Deficit Hyperactivity Disorder (ADHD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Distribution Channel for the period 2017-2028.
Segment by Type
Stimulant
Non-stimulant
Segment by Distribution Channel
Hospital Pharmacy
Retail Pharmacy
By Company
Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
CTFH
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Effective treatment of ADHD. ADHD refers to a group of syndromes that occur in childhood and are characterized by obvious difficulty in concentration, short duration of attention, hyperactivity or impulsivity compared with children of the same age.
Market Analysis and Insights: Global Attention Deficit Hyperactivity Disorder (ADHD) Market
The global Attention Deficit Hyperactivity Disorder (ADHD) market size is projected to reach US$ 19380 million by 2028, from US$ 12240 million in 2021, at a CAGR of 6.7% during 2022-2028.
There are two main types of drugs used to treat ADHD: stimulants and non-stimulants
The main manufacturers of stimulants are in Europe and America, and the main manufacturers of non-stimulants are in China.
ADHD is mainly used in hospital pharmacies and retail pharmacies. Among them, in 2020, the market share of retail pharmacies accounted for approximately 83%
Takeda has the highest market share in ADHD by major global companies, which is much higher than the market share of other companies, about 21% in 2020.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Attention Deficit Hyperactivity Disorder (ADHD) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Attention Deficit Hyperactivity Disorder (ADHD) market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Attention Deficit Hyperactivity Disorder (ADHD) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Attention Deficit Hyperactivity Disorder (ADHD) market.
Global Attention Deficit Hyperactivity Disorder (ADHD) Scope and Market Size
Attention Deficit Hyperactivity Disorder (ADHD) market is segmented by players, region (country), by Type and by Distribution Channel. Players, stakeholders, and other participants in the global Attention Deficit Hyperactivity Disorder (ADHD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Distribution Channel for the period 2017-2028.
Segment by Type
Stimulant
Non-stimulant
Segment by Distribution Channel
Hospital Pharmacy
Retail Pharmacy
By Company
Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
CTFH
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Index1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Stimulant
1.2.3 Non-stimulant
1.3 Market by Distribution Channel
1.3.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Distribution Channel, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Perspective (2017-2028)
2.2 Attention Deficit Hyperactivity Disorder (ADHD) Growth Trends by Region
2.2.1 Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Attention Deficit Hyperactivity Disorder (ADHD) Historic Market Size by Region (2017-2022)
2.2.3 Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Region (2023-2028)
2.3 Attention Deficit Hyperactivity Disorder (ADHD) Market Dynamics
2.3.1 Attention Deficit Hyperactivity Disorder (ADHD) Industry Trends
2.3.2 Attention Deficit Hyperactivity Disorder (ADHD) Market Drivers
2.3.3 Attention Deficit Hyperactivity Disorder (ADHD) Market Challenges
2.3.4 Attention Deficit Hyperactivity Disorder (ADHD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Attention Deficit Hyperactivity Disorder (ADHD) Players by Revenue
3.1.1 Global Top Attention Deficit Hyperactivity Disorder (ADHD) Players by Revenue (2017-2022)
3.1.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Players (2017-2022)
3.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Attention Deficit Hyperactivity Disorder (ADHD) Revenue
3.4 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Concentration Ratio
3.4.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Attention Deficit Hyperactivity Disorder (ADHD) Revenue in 2021
3.5 Attention Deficit Hyperactivity Disorder (ADHD) Key Players Head office and Area Served
3.6 Key Players Attention Deficit Hyperactivity Disorder (ADHD) Product Solution and Service
3.7 Date of Enter into Attention Deficit Hyperactivity Disorder (ADHD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Attention Deficit Hyperactivity Disorder (ADHD) Breakdown Data by Type
4.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Historic Market Size by Type (2017-2022)
4.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Type (2023-2028)
5 Attention Deficit Hyperactivity Disorder (ADHD) Breakdown Data by Distribution Channel
5.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Historic Market Size by Distribution Channel (2017-2022)
5.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Distribution Channel (2023-2028)
6 North America
6.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2017-2028)
6.2 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type
6.2.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2017-2022)
6.2.2 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2023-2028)
6.2.3 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type (2017-2028)
6.3 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel
6.3.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2017-2022)
6.3.2 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2023-2028)
6.3.3 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Distribution Channel (2017-2028)
6.4 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country
6.4.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2017-2022)
6.4.2 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2017-2028)
7.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type
7.2.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2017-2022)
7.2.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2023-2028)
7.2.3 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type (2017-2028)
7.3 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel
7.3.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2017-2022)
7.3.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2023-2028)
7.3.3 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Distribution Channel (2017-2028)
7.4 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country
7.4.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2017-2022)
7.4.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2017-2028)
8.2 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type
8.2.1 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type (2017-2028)
8.3 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel
8.3.1 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2017-2022)
8.3.2 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2023-2028)
8.3.3 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Distribution Channel (2017-2028)
8.4 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region
8.4.1 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2017-2028)
9.2 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type
9.2.1 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2017-2022)
9.2.2 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2023-2028)
9.2.3 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type (2017-2028)
9.3 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel
9.3.1 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2017-2022)
9.3.2 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2023-2028)
9.3.3 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Distribution Channel (2017-2028)
9.4 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country
9.4.1 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2017-2022)
9.4.2 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2017-2028)
10.2 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type
10.2.1 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type (2017-2028)
10.3 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel
10.3.1 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2017-2022)
10.3.2 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2023-2028)
10.3.3 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Distribution Channel (2017-2028)
10.4 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country
10.4.1 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.1.4 Takeda Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
11.1.5 Takeda Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.2.4 Johnson & Johnson Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
11.2.5 Johnson & Johnson Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.3.4 Novartis Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
11.3.5 Novartis Recent Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.4.4 Eli Lilly Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
11.4.5 Eli Lilly Recent Developments
11.5 Tris Pharma
11.5.1 Tris Pharma Company Details
11.5.2 Tris Pharma Business Overview
11.5.3 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.5.4 Tris Pharma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
11.5.5 Tris Pharma Recent Developments
11.6 Neos Therapeutics
11.6.1 Neos Therapeutics Company Details
11.6.2 Neos Therapeutics Business Overview
11.6.3 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.6.4 Neos Therapeutics Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
11.6.5 Neos Therapeutics Recent Developments
11.7 Mallinckrodt
11.7.1 Mallinckrodt Company Details
11.7.2 Mallinckrodt Business Overview
11.7.3 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.7.4 Mallinckrodt Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
11.7.5 Mallinckrodt Recent Developments
11.8 Amneal Pharmaceuticals
11.8.1 Amneal Pharmaceuticals Company Details
11.8.2 Amneal Pharmaceuticals Business Overview
11.8.3 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.8.4 Amneal Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
11.8.5 Amneal Pharmaceuticals Recent Developments
11.9 Noven Pharmaceuticals
11.9.1 Noven Pharmaceuticals Company Details
11.9.2 Noven Pharmaceuticals Business Overview
11.9.3 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.9.4 Noven Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
11.9.5 Noven Pharmaceuticals Recent Developments
11.10 Purdue Parma
11.10.1 Purdue Parma Company Details
11.10.2 Purdue Parma Business Overview
11.10.3 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.10.4 Purdue Parma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
11.10.5 Purdue Parma Recent Developments
11.11 CTFH
11.11.1 CTFH Company Details
11.11.2 CTFH Business Overview
11.11.3 CTFH Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.11.4 CTFH Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
11.11.5 CTFH Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Stimulant
Table 3. Key Players of Non-stimulant
Table 4. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Distribution Channel (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Region (2017-2022)
Table 8. Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Region (2023-2028)
Table 10. Attention Deficit Hyperactivity Disorder (ADHD) Market Trends
Table 11. Attention Deficit Hyperactivity Disorder (ADHD) Market Drivers
Table 12. Attention Deficit Hyperactivity Disorder (ADHD) Market Challenges
Table 13. Attention Deficit Hyperactivity Disorder (ADHD) Market Restraints
Table 14. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Players (2017-2022)
Table 16. Global Top Attention Deficit Hyperactivity Disorder (ADHD) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Attention Deficit Hyperactivity Disorder (ADHD) as of 2021)
Table 17. Ranking of Global Top Attention Deficit Hyperactivity Disorder (ADHD) Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Attention Deficit Hyperactivity Disorder (ADHD) Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Attention Deficit Hyperactivity Disorder (ADHD) Product Solution and Service
Table 21. Date of Enter into Attention Deficit Hyperactivity Disorder (ADHD) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Type (2017-2022)
Table 25. Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Type (2023-2028)
Table 27. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2017-2022) & (US$ Million)
Table 28. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Distribution Channel (2017-2022)
Table 29. Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Distribution Channel (2023-2028) & (US$ Million)
Table 30. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Distribution Channel (2023-2028)
Table 31. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2017-2022) & (US$ Million)
Table 34. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2023-2028) & (US$ Million)
Table 35. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2017-2022) & (US$ Million)
Table 40. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2023-2028) & (US$ Million)
Table 41. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2017-2022) & (US$ Million)
Table 46. Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2023-2028) & (US$ Million)
Table 47. Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2017-2022) & (US$ Million)
Table 52. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2023-2028) & (US$ Million)
Table 53. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2023-2028) & (US$ Million)
Table 61. Takeda Company Details
Table 62. Takeda Business Overview
Table 63. Takeda Attention Deficit Hyperactivity Disorder (ADHD) Product
Table 64. Takeda Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022) & (US$ Million)
Table 65. Takeda Recent Developments
Table 66. Johnson & Johnson Company Details
Table 67. Johnson & Johnson Business Overview
Table 68. Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Product
Table 69. Johnson & Johnson Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022) & (US$ Million)
Table 70. Johnson & Johnson Recent Developments
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Attention Deficit Hyperactivity Disorder (ADHD) Product
Table 74. Novartis Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022) & (US$ Million)
Table 75. Novartis Recent Developments
Table 76. Eli Lilly Company Details
Table 77. Eli Lilly Business Overview
Table 78. Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Product
Table 79. Eli Lilly Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022) & (US$ Million)
Table 80. Eli Lilly Recent Developments
Table 81. Tris Pharma Company Details
Table 82. Tris Pharma Business Overview
Table 83. Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Product
Table 84. Tris Pharma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022) & (US$ Million)
Table 85. Tris Pharma Recent Developments
Table 86. Neos Therapeutics Company Details
Table 87. Neos Therapeutics Business Overview
Table 88. Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Product
Table 89. Neos Therapeutics Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022) & (US$ Million)
Table 90. Neos Therapeutics Recent Developments
Table 91. Mallinckrodt Company Details
Table 92. Mallinckrodt Business Overview
Table 93. Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Product
Table 94. Mallinckrodt Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022) & (US$ Million)
Table 95. Mallinckrodt Recent Developments
Table 96. Amneal Pharmaceuticals Company Details
Table 97. Amneal Pharmaceuticals Business Overview
Table 98. Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product
Table 99. Amneal Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022) & (US$ Million)
Table 100. Amneal Pharmaceuticals Recent Developments
Table 101. Noven Pharmaceuticals Company Details
Table 102. Noven Pharmaceuticals Business Overview
Table 103. Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product
Table 104. Noven Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022) & (US$ Million)
Table 105. Noven Pharmaceuticals Recent Developments
Table 106. Purdue Parma Company Details
Table 107. Purdue Parma Business Overview
Table 108. Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Product
Table 109. Purdue Parma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022) & (US$ Million)
Table 110. Purdue Parma Recent Developments
Table 111. CTFH Company Details
Table 112. CTFH Business Overview
Table 113. CTFH Attention Deficit Hyperactivity Disorder (ADHD) Product
Table 114. CTFH Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022) & (US$ Million)
Table 115. CTFH Recent Developments
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type: 2021 VS 2028
Figure 2. Stimulant Features
Figure 3. Non-stimulant Features
Figure 4. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Distribution Channel: 2021 VS 2028
Figure 5. Hospital Pharmacy Case Studies
Figure 6. Retail Pharmacy Case Studies
Figure 7. Attention Deficit Hyperactivity Disorder (ADHD) Report Years Considered
Figure 8. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Region: 2021 VS 2028
Figure 11. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Players in 2021
Figure 12. Global Top Attention Deficit Hyperactivity Disorder (ADHD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Attention Deficit Hyperactivity Disorder (ADHD) as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Attention Deficit Hyperactivity Disorder (ADHD) Revenue in 2021
Figure 14. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY (2017-2028) & (US$ Million)
Figure 15. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Type (2017-2028)
Figure 16. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Distribution Channel (2017-2028)
Figure 17. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size Share by Country (2017-2028)
Figure 18. United States Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY (2017-2028) & (US$ Million)
Figure 21. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Type (2017-2028)
Figure 22. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Distribution Channel (2017-2028)
Figure 23. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size Share by Country (2017-2028)
Figure 24. Germany Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY (2017-2028) & (US$ Million)
Figure 31. Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Type (2017-2028)
Figure 32. Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Distribution Channel (2017-2028)
Figure 33. Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size Share by Region (2017-2028)
Figure 34. China Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY (2017-2028) & (US$ Million)
Figure 41. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Type (2017-2028)
Figure 42. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Distribution Channel (2017-2028)
Figure 43. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size Share by Country (2017-2028)
Figure 44. Mexico Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Brazil Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Type (2017-2028)
Figure 48. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Distribution Channel (2017-2028)
Figure 49. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size Share by Country (2017-2028)
Figure 50. Turkey Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. UAE Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Takeda Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
Figure 54. Johnson & Johnson Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
Figure 55. Novartis Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
Figure 56. Eli Lilly Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
Figure 57. Tris Pharma Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
Figure 58. Neos Therapeutics Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
Figure 59. Mallinckrodt Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
Figure 60. Amneal Pharmaceuticals Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
Figure 61. Noven Pharmaceuticals Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
Figure 62. Purdue Parma Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
Figure 63. CTFH Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
